IGL-1 preservation solution in kidney and pancreas transplantation: A systematic review.

We aimed to systematically review published data on the effectiveness of Institut Georges Lopez-1 (IGL-1) as a preservation solution for kidney and pancreas grafts. A systematic literature search of PubMed, Embase, Web of Science, and the Cochrane Library databases was performed. Human studies evalu...

Full description

Bibliographic Details
Main Authors: Melanie Habran, Julie De Beule, Ina Jochmans
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0231019
id doaj-2ad3775547b144dabc4311884c3ce01b
record_format Article
spelling doaj-2ad3775547b144dabc4311884c3ce01b2021-03-03T21:39:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01154e023101910.1371/journal.pone.0231019IGL-1 preservation solution in kidney and pancreas transplantation: A systematic review.Melanie HabranJulie De BeuleIna JochmansWe aimed to systematically review published data on the effectiveness of Institut Georges Lopez-1 (IGL-1) as a preservation solution for kidney and pancreas grafts. A systematic literature search of PubMed, Embase, Web of Science, and the Cochrane Library databases was performed. Human studies evaluating the effects of IGL-1 preservation solution in kidney and/or pancreas transplantation were included. Outcome data on kidney and pancreas graft function were extracted. Of 1513 unique articles identified via the search strategy, four articles could be included in the systematic review. Of these, two retrospective studies reported on the outcome of IGL-1 compared to University of Wisconsin (UW) solution in kidney transplantation. These show kidneys preserved in IGL-1 had improved early function (2 weeks post-transplant) compared to UW. Follow-up was limited to 1 year and showed similar graft and patient survival rates when reported. Two case series described acceptable early outcomes (up to 1 month) of simultaneous kidney pancreas transplantation after storage in IGL-1. As only four clinical papers were identified, we widened our search to include four eligible large animal studies. Three compared IGL-1 with UW in pig kidney transplant models with inconclusive or mildly positive results. One pig pancreas transplant study suggested better early outcome with IGL-1 compared to UW. Too few published data are available to allow any firm conclusions to be drawn on the effectiveness of IGL-1 as a preservation solution of kidney and pancreas grafts. The limited available data show satisfactory early outcomes though no medium to long-term outcomes have been described. Further well-designed clinical studies are needed.https://doi.org/10.1371/journal.pone.0231019
collection DOAJ
language English
format Article
sources DOAJ
author Melanie Habran
Julie De Beule
Ina Jochmans
spellingShingle Melanie Habran
Julie De Beule
Ina Jochmans
IGL-1 preservation solution in kidney and pancreas transplantation: A systematic review.
PLoS ONE
author_facet Melanie Habran
Julie De Beule
Ina Jochmans
author_sort Melanie Habran
title IGL-1 preservation solution in kidney and pancreas transplantation: A systematic review.
title_short IGL-1 preservation solution in kidney and pancreas transplantation: A systematic review.
title_full IGL-1 preservation solution in kidney and pancreas transplantation: A systematic review.
title_fullStr IGL-1 preservation solution in kidney and pancreas transplantation: A systematic review.
title_full_unstemmed IGL-1 preservation solution in kidney and pancreas transplantation: A systematic review.
title_sort igl-1 preservation solution in kidney and pancreas transplantation: a systematic review.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description We aimed to systematically review published data on the effectiveness of Institut Georges Lopez-1 (IGL-1) as a preservation solution for kidney and pancreas grafts. A systematic literature search of PubMed, Embase, Web of Science, and the Cochrane Library databases was performed. Human studies evaluating the effects of IGL-1 preservation solution in kidney and/or pancreas transplantation were included. Outcome data on kidney and pancreas graft function were extracted. Of 1513 unique articles identified via the search strategy, four articles could be included in the systematic review. Of these, two retrospective studies reported on the outcome of IGL-1 compared to University of Wisconsin (UW) solution in kidney transplantation. These show kidneys preserved in IGL-1 had improved early function (2 weeks post-transplant) compared to UW. Follow-up was limited to 1 year and showed similar graft and patient survival rates when reported. Two case series described acceptable early outcomes (up to 1 month) of simultaneous kidney pancreas transplantation after storage in IGL-1. As only four clinical papers were identified, we widened our search to include four eligible large animal studies. Three compared IGL-1 with UW in pig kidney transplant models with inconclusive or mildly positive results. One pig pancreas transplant study suggested better early outcome with IGL-1 compared to UW. Too few published data are available to allow any firm conclusions to be drawn on the effectiveness of IGL-1 as a preservation solution of kidney and pancreas grafts. The limited available data show satisfactory early outcomes though no medium to long-term outcomes have been described. Further well-designed clinical studies are needed.
url https://doi.org/10.1371/journal.pone.0231019
work_keys_str_mv AT melaniehabran igl1preservationsolutioninkidneyandpancreastransplantationasystematicreview
AT juliedebeule igl1preservationsolutioninkidneyandpancreastransplantationasystematicreview
AT inajochmans igl1preservationsolutioninkidneyandpancreastransplantationasystematicreview
_version_ 1714815737459113984